NGM

NGM Biopharmaceuticals, Inc. Common Stock

Delisted

NGM was delisted on the 4th of April, 2024.

114 hedge funds and large institutions have $730M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 38 increasing their positions, 40 reducing their positions, and 20 closing their positions.

Holders
114
Holders Change
-5
Holders Change %
-4.2%
% of All Funds
1.8%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
15
Increased
38
Reduced
40
Closed
20
Calls
$41K
Puts
Net Calls
+$41K
Net Calls Change
-$1.54M